Genetic Changes at the Glycoprotein Editing Site Associated with Serial Passage of Sudan Virus

Journal of Infectious Diseases

Volumn 212, Issue , 2015, Pages S295-S304

  Alfson, Kendra J ^a,b   Avena, Laura E ^a   Beadles, Michael W ^a   Menzie, Heather ^a,b   Patterson, Jean L ^a   Carrion, Ricardo ^a   Griffiths, Anthony ^a,b  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

cell culture adaptation; editing site; glycoprotein; RNA editing; Sudan virus

Indexed keywords

VIRUS GLYCOPROTEIN; GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FILOVIRUS; FILOVIRUS INFECTION; GENOTYPE; MACACA FASCICULARIS; MALE; NONHUMAN; PRIMATE MODEL; PRIORITY JOURNAL; RNA EDITING; RNA EDITING SITE; SUDAN VIRUS; SUDAN VIRUS INFECTION; VERO CELL LINE; VIRAL GENETICS; VIRUS CULTURE; VIRUS VIRULENCE; ANIMAL; CHLOROCEBUS AETHIOPS; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; GENETICS; HAPLORHINI; PATHOGENICITY; PROCEDURES; SUDAN; VIROLOGY; VIRULENCE; VIRUS GENOME; VIRUS LOAD;

ANIMALS; CERCOPITHECUS AETHIOPS; EBOLAVIRUS; GENOME, VIRAL; GLYCOPROTEINS; HAPLORHINI; HEMORRHAGIC FEVER, EBOLA; RNA EDITING; SERIAL PASSAGE; SUDAN; VERO CELLS; VIRAL LOAD; VIRULENCE;

EID: 84943303240     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv216     Document Type: Article

References (30)

1. Marsh GA, Haining J, Robinson R, et al. Ebola reston virus infection of pigs: clinical significance and transmission potential. J Infect Dis 2011; 204(suppl 3):S804-9.
2. Martina BEE, Osterhaus ADME. "Filoviruses": A real pandemic threat? EMBO Mol Med 2009; 1:10-8.
3. Swanepoel R, Leman PA, Burt FJ, et al. Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis 1996; 2:321-5.
4. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014; 371:1418-25.
5. Sobrino F, Dávila M, Ortín J, Domingo E. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 1983; 128:310-8.
6. Domingo E, Escarmís C, Sevilla N, et al. Basic concepts in RNA virus evolution. FASEB J 1996; 10:859-64.
7. Holland J, Spindler K, Horodyski F, Grabau E, Nichol S, VandePol S. Rapid evolution of RNA genomes. Science 1982; 215:1577-85.
8. Kugelman JR, Lee MS, Rossi CA, et al. Ebola virus genome plasticity as a marker of its passaging history: A comparison of in vitro passaging to non-human primate infection. PLoS One 2012; 7:e50316.
9. Sanchez A, Trappier SG, Mahy BW, Peters CJ, Nichol ST. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A 1996; 93:3602-7.
10. Mehedi M. Ebola virus RNA editing: characterization of the mechanism and gene products [dissertation]. Winnipeg, Canada: University of Manitoba, 2011.
11. Mehedi M, Hoenen T, Robertson S, et al. Ebola virus RNA editing depends on the primary editing site sequence and an upstream secondary structure. PLoS Pathog 2013; 9:e1003677.
12. Volchkova VA, Dolnik O, Martinez MJ, Reynard O, Volchkov VE. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs. J Infect Dis 2011; 204(suppl 3):S941-6.
13. Shabman RS, Jabado OJ, Mire CE, et al. Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells. MBio 2014; 5:e02011.
14. Mehedi M, Falzarano D, Seebach J, et al. A new Ebola virus nonstructural glycoprotein expressed through RNA editing. J Virol 2011; 85:5406-14.
15. Escudero-Pérez B, Volchkova VA, Dolnik O, Lawrence P, Volchkov VE. Shed GP of Ebola virus triggers immune activation and increased vascular permeability. PLoS Pathog 2014; 10:e1004509.
16. Wahl-Jensen VM, Afanasieva TA, Seebach J, Ströher U, Feldmann H, Schnittler H-J. Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol 2005; 79:10442-50.
17. Groseth A, Marzi A, Hoenen T, Herwig A, Gardner D. The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. PLoS Pathog 2012; 8:e1002847.
18. Volchkov VE, Feldmann H, Volchkova VA, Klenk HD. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A 1998; 95:5762-7.
19. Alazard-Dany N, Volchkova V. Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level. J Gen 2006; 87:1247-57.
20. National Research Council. Guide for the care and use of laboratory animals. 8th ed. Washington, DC: National Academies Press, 2011.
21. Shurtleff A, Biggins J, Keeney A, et al. Standardization of the filovirus plaque assay for use in preclinical studies. Viruses 2012; 4:3511-30.
22. Alfson KJ, Beadles MW, Griffiths A. A new approach to determining whole viral genomic sequences including termini using a single deep sequencing run. J Virol Methods 2014; 208:1-5.
23. Geisbert TW, Hensley LE, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003; 163:2347-70.
24. Carrion R, Ro Y, Hoosien K, et al. A small nonhuman primate model for filovirus-induced disease. Virology 2011; 420:117-24.
25. Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med 2000; 6:886-9.
26. Sullivan N, Yang Z-Y, Nabel GJ. Ebola virus pathogenesis: implications for vaccines and therapies. J Virol 2003; 77:9733-7.
27. Simmons G,Wool-Lewis RJ, Baribaud F, Netter RC, Bates P. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Virol 2002; 76:2518-28.
28. Takada A, Watanabe S, Ito H, Okazaki K, Kida H, Kawaoka Y. Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 2000; 278:20-6.
29. Falzarano D, Krokhin O,Wahl-Jensen V, et al. Structure-function analysis of the soluble glycoprotein, sGP, of Ebola virus. Chembiochem 2006; 7:1605-11.
30. Sanchez A, Lukwiya M, Bausch D, et al. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol 2004; 78:10370-7.